S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
A Full Year Of Recommended Stock Picks Now 60% Off (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
A Full Year Of Recommended Stock Picks Now 60% Off (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
A Full Year Of Recommended Stock Picks Now 60% Off (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
A Full Year Of Recommended Stock Picks Now 60% Off (Ad)
BATS:VLUE

iShares MSCI USA Value Factor ETF - VLUE Stock Forecast, Price & News

$95.51
+0.24 (+0.25%)
(As of 08/8/2022 04:00 PM ET)
Add
Today's Range
$95.28
$96.18
50-Day Range
$88.40
$102.47
52-Week Range
$71.21
$89.40
Volume
709,764 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Receive VLUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares MSCI USA Value Factor ETF and its competitors with MarketBeat's FREE daily newsletter.

Receive VLUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares MSCI USA Value Factor ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares MSCI USA Value Factor ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:VLUE
Inception Date4/16/2013
Fund ManagerJennifer Hsui, Paul Whitehead, Greg Savage, Amy Whitelaw
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMSCI USA Enhanced Value Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$8.99 billion
Average Daily Volume$797,930.70
Discount/Premium-0.03%

ETF Expenses

Management Fee0.15%
Other Expenses0.00%
Total Expenses0.15%
Fee Waiver0.00%
Net Expenses0.15%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerJane Street

Geographic Exposure of VLUE

Currency Exposure of VLUE

Sector Exposure of VLUE

Industry Exposure of VLUE














VLUE Stock - Frequently Asked Questions

How has iShares MSCI USA Value Factor ETF's stock price performed in 2022?

iShares MSCI USA Value Factor ETF's stock was trading at $109.47 at the start of the year. Since then, VLUE stock has decreased by 12.8% and is now trading at $95.51.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of iShares MSCI USA Value Factor ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares MSCI USA Value Factor ETF investors own include Alibaba Group (BABA), Intel (INTC), AT&T (T), Gilead Sciences (GILD), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE), QUALCOMM (QCOM), SPDR S&P 500 ETF Trust (SPY) and AbbVie (ABBV).

What is iShares MSCI USA Value Factor ETF's stock symbol?

iShares MSCI USA Value Factor ETF trades on the BATS under the ticker symbol "VLUE."

Who are iShares MSCI USA Value Factor ETF's major shareholders?

iShares MSCI USA Value Factor ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Northwestern Mutual Wealth Management Co. (0.00%), Envestnet Asset Management Inc. (0.00%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.00%), Matson Money. Inc. (0.00%), M&T Bank Corp (0.00%) and Signature Estate & Investment Advisors LLC (0.00%).

How do I buy shares of iShares MSCI USA Value Factor ETF?

Shares of VLUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares MSCI USA Value Factor ETF's stock price today?

One share of VLUE stock can currently be purchased for approximately $95.51.

This page (BATS:VLUE) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.